University Of Iowa Doctors Study Effects Of Vitamin C In Cancer Treatments

As evidenced by an important article published by the United States National Cancer Institute (NCI) in January 2020, it seems likely that the next stage in vitamin C’s long journey towards the cancer mainstream may involve coupling it with conventional treatments such as chemotherapy and radiation.

In what will clearly be seen by the pharma industry as a major threat to its multibillion-dollar cancer drug business, the NCI article authors evaluated high-dose intravenous vitamin C therapy in their article and concluded that “given the current high financial cost of new cancer drugs, it seems rational to improve the effectiveness of current therapies by studying their clinical interactions with vitamin C.” The authors predicted that “the implementation of this treatment paradigm could provide benefit to many cancer patients.”

Using high-dose vitamin C alongside conventional cancer treatments will ultimately only be a stepping-stone, however. Cutting-edge studies conducted at the Dr. Rath Research Institute have already demonstrated that combining vitamin C with a group of other specific micronutrients enables the blocking of all key mechanisms that make cancer a deadly disease.

As described in the book ‘Victory Over Cancer’, authored by Dr. Rath and Dr. Aleksandra Niedzwiecki, these micronutrients are able to block the secretion of the collagen digesting enzymes produced by cancer cells, inhibit the invasion and metastasis of cancer cells, block the growth of tumors and the formation of new blood vessels to feed them, and induce the natural death of cancer cells. There is no single existing cancer drug or other conventional treatment that can effectively and safely achieve all of these things simultaneously.

To watch an in-depth interview with Dr. Rath and Dr. Niedzwiecki from ‘The Truth About Cancer’ documentary, see this page on our website.